Impact of zygomycosis on microbiology workload: A survey study in Spain

Journal of Clinical Microbiology

Volumn 45, Issue 6, 2007, Pages 2051-2053

  Torres Narbona, Marta ^a   Guinea, Jesús ^a   Martínez Alarcón, José ^a   Muñoz, Patricia ^a   Gadea, Ignacio ^a   Bouza, Emilio ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

VORICONAZOLE;

ARTICLE; DIABETES MELLITUS; HOSPITAL ADMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY; LEUKEMIA; LYMPHOMA; MUCORMYCOSIS; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; SPAIN; WORKLOAD; ZYGOMYCETES;

HEALTH CARE SURVEYS; HOSPITALS, GENERAL; HOSPITALS, TEACHING; HUMANS; INCIDENCE; LABORATORIES, HOSPITAL; MICROBIOLOGY; POPULATION SURVEILLANCE; SPAIN; WORKLOAD; ZYGOMYCOSIS; ZYGOMYCOTA;

ZYGOMYCETES;

EID: 34250654884     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02473-06     Document Type: Article

References (30)

1. Ascioglu, S., J. H. Rex, B. de Pauw, J. E. Bennett, J. Bille, F. Crokaert, D. W. Denning, J. P. Donnelly, J. E. Edwards, Z. Erjavec, D. Fiere, O. Lortholary, J. Maertens, J. F. Meis, T. F. Patterson, J. Ritter, D. Selleslag, P. M. Shah, D. A. Stevens, and T. J. Walsh. 2002. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin. Infect. Dis. 34:7-14.
2. Bigby, T. D., M. L. Serota, L. M. Tierney, Jr., and M. A. Matthay. 1986. Clinical spectrum of pulmonary mucormycosis. Chest 89:435-439.
3. Boletín Oficial del Estado. 2005. Real decreto 1358/2005, p. 39422-39423. Ministry of Health, Madrid, Spain.
4. Guinea, J., T. Peláez, P. Muñoz, and E. Bouza. 2005. How frequent are agents responsible for mucormycosis in outdoor air? Abstr. 45th Intersci. Conf. Antimicrob. Agents Chemother., abstr. M-962. American Society for Microbiology, Washington, DC.
5. Hotchi, M., M. Okada, and T. Nasu. 1980. Present state of fungal infections in autopsy cases in Japan. Am. J. Clin. Pathol. 74:410-416.
6. Imhof, A., S. A. Balajee, D. N. Fredricks, J. A. Englund, and K. A. Marr. 2004. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin. Infect. Dis. 39:743-746.
7. Jacobs, P., L. Wood, A. Du Toit, and K. Esterhuizen. 2003. Eradication of invasive mucormycosis-effectiveness of the echinocandin FK463. Hematology 8:119-123.
8. Kauffman, C. A. 2004. Zygomycosis: reemergence of an old pathogen. Clin. Infect. Dis. 39:588-590.
9. Kobayashi, K., M. Kami, N. Murashige, Y. Kishi, G. Fujisaki, and T. Mitamura. 2004. Breakthrough zygomycosis during voriconazole treatment for invasive aspergillosis. Haematologica 89:ECR42.
10. Kontoyiannis, D. P., M. S. Lionakis, R. E. Lewis, G. Chamilos, M. Healy, C. Perego, A. Safdar, H. Kantarjian, R. Champlin, T. J. Walsh, and I. I. Raad. 2005. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J. Infect. Dis. 191:1350-1359.
11. Lionakis, M. S., and D. P. Kontoyiannis. 2004. The significance of isolation of saprophytic molds from the lower respiratory tract in patients with cancer. Cancer 100:165-172.
12. Lionakis, M. S., and D. P. Kontoyiannis. 2005. Sinus zygomycosis in a patient receiving voriconazole prophylaxis. Br. J. Haematol. 129:2.
13. Marr, K. A., R. A. Carter, F. Crippa, A. Wald, and L. Corey. 2002. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 34:909-917.
14. Marty, F. M., L. A. Cosimi, and L. R. Baden. 2004. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N. Engl. J. Med. 350:950-952.
15. Oren, I. 2005. Breakthrough zygomycosis during empirical voriconazole therapy in febrile patients with neutropenia. Clin. Infect. Dis. 40:770-771.
16. Pagano, L., M. Caira, and L. Fianchi. 2005. Pulmonary fungal infection with yeasts and Pneumocystis in patients with hematological malignancy. Ann. Med. 37:259-269.
17. Pagano, L., M. Offidani, L. Fianchi, A. Nosari, A. Candoni, M. Piccardi, L. Corvatta, D. D'Antonio, C. Girmenia, P. Martino, and A. Del Favero. 2004. Mucormycosis in hematologic patients. Haematologica 89:207-214.
18. Peláez, T., J. Guinea, J. Martínez- Alarcón, P. Muñoz, C. Bové, and E. Bouza. 2005. Are agents responsible for mucormycosis commonly found in hospital air? Analysis of air samples in a general hospital over a six-year period. Abstr. 45th Intersci. Conf. Antimicrob. Agents Chemother., abstr. M-963. American Society for Microbiology, Washington, DC.
19. Rees, J. R., R. W. Pinner, R. A. Hajjeh, M. E. Brandt, and A. L. Reingold. 1998. The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: results of population-based laboratory active surveillance. Clin. Infect. Dis. 27:1138-1147.
20. Rickerts, V., A. Bohme, and G. Just-Nubling. 2002. Risk factor for invasive zygomycosis in patients with hematologic malignancies. Mycoses 45:27-30.
21. Ritz, N., R. A. Ammann, C. C. Aebischer, M. Gugger, K. Jaton, R. A. Schmid, and C. Aebi. 2005. Failure of voriconazole to cure disseminated zygomycosis in an immunocompromised child. Eur. J. Pediatr. 164:231-235.
22. Singh, S. K., P. Wadhwa, and V. Sakhuja. 2004. Isolated bilateral renal mucormycosis. Urology 63:979-980.
23. Siwek, G. T., K. J. Dodgson, M. de Magalhaes-Silverman, L. A. Bartelt, S. B. Kilborn, P. L. Hoth, D. J. Diekema, and M. A. Pfaller. 2004. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin. Infect. Dis. 39:584-587.
24. Takabayashi, M., R. Sakai, H. Sakamoto, M. Kakinuma, Y. Iemoto, H. Kanamori, and Y. Ishigatsubo. 2004. Cutaneous mucormycosis during induction chemotherapy for acute lymphocytic leukemia. Leuk. Lymphoma 45:199-200.
25. Tietz, H. J., D. Brehmer, W. Janisch, and H. Martin. 1998. Incidence of endomycoses in the autopsy material of the Berlin Charite Hospital. Mycoses 41:81-85.
26. Verma, A., S. Williams, S. Trifilio, T. Zembower, and J. Mehta. 2004. Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease. Bone Marrow Transplant. 33:1065-1066.
27. Vigouroux, S., O. Morin, P. Moreau, F. Mechinaud, N. Morineau, B. Mahe, P. Chevallier, T. Guillaume, V. Dubruille, J. L. Harousseau, and N. Milpied. 2005. Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required. Clin. Infect. Dis. 40:e35-e37. [Epub ahead of print.]
28. Walsh, T. J., A. Groll, J. Hiemenz, R. Fleming, E. Roilides, and E. Anaissie. 2004. Infections due to emerging and uncommon medically important fungal pathogens. Clin. Microbiol. Infect. 10:48-66.
29. Wingard, J. R. 2005. The changing face of invasive fungal infections in hematopoietic cell transplant recipients. Curr. Opin. Oncol. 17:89-92.
30. Yamazaki, T., H. Kume, S. Murase, E. Yamashita, and M. Arisawa. 1999. Epidemiology of visceral mycoses: analysis of data in annual of the pathological autopsy cases in Japan. J. Clin. Microbiol. 37:1732-1738.